PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 6(3) | 59-66
Article title

Recommendation for use of Sinupret extract in acute rhinosinusitis

Content
Title variants
Languages of publication
Abstracts
EN
Acute and chronic rhinosinusitis is the most common problem encountered in ENT practice. Nearly all cases of acute rhinosinusitis are of viral background. Further course of the disease is determined by the condition of mucosal membranes, systemic immune strength, virulence of the infectious agent and the morphology of paranasal sinuses. Medications used in acute rhinosinusitis provide symptomatic treatment, their effect being aimed at reduction of inflammation and swelling. Products obtained from medicinal plants may provide an alternative to these medications. In vitro studies have shown that these products demonstrate anti-inflammatory, immunostimulating, anti-edemic, and antiviral effects. With the market placement of Sinupret extract, the armamentarium of therapeutic has been extended by a concentrated product characterized by strength comparable to that of synthetic analgesic and anti-inflammatory drug as well as by additional, documented antiviral effect. The article discusses the composition of Sinupret extract, the mechanisms of action of its active substances, and the results of preclinical and clinical studies of Sinupret and Sinupret extract.
Year
Volume
Pages
59-66
Physical description
Dates
published
2017-09-11
Contributors
References
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.ceon.element-1019503e-0346-3180-b6dc-6cf570b4a4e8
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.